Article Text

FRI0032 Increased level of IL-34 in serum and synovial fluid is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibodies titer in patients with rheumatoid arthritis
  1. S.-J. Moon1,
  2. J.-K. Min1,
  3. Y.-S. Hong1
  1. 1Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, Korea, Republic Of


Background Interleukin-34 (IL-34) is a recently discovered cytokine that binds macrophage colony-stimulating factor (M-CSF). Rheumatoid arthritis (RA) is a representative inflammatory arthritis characterized by increased osteoclastogenesis, which contributes to joint destruction and generalized bone loss.

Objectives To identify the possible pathophysiological significance of IL-34 in RA, the level of this cytokine was measured in serum and synovial fluid (SF) from patients with RA.

Methods IL-34 levels were measured in serum from 113 patients with RA, 56 patients with osteoarthritis (OA), and 36 controls, and in SF isolated from patients with RA (n = 36) or OA (n = 24). Correlations between serum IL-34 concentration and clinical and laboratory features, RA disease activity score, and bone mineral density (BMD) were assessed in RA patients. The levels of IL-1β, IL-6, IL-17α, interferon-γ-induced protein 10 (IP-10), receptor activator of nuclear factor kB ligand (RANKL), and dickkopf-1 (DKK-1), which are implicated in osteoclastogenesis, were also measured in serum and SF samples.

Results RA patients had a significantly higher mean serum level of IL-34 than did OA patients and controls (188.0 ± 550.3, 36.6 ± 38.0, and 49.1 ± 78.5 pg/ml, respectively). Similarly, mean SF IL-34 concentration was also higher in RA than in OA patients. Paired samples isolated from seven RA patients showed similar levels of IL-34 in serum and SF. In serum from RA and OA patients, IL-34 levels were positively associated with IL-6 levels. SF IL-34 concentration correlated significantly with IL-6 (r = 0.482) and RANKL (r = 0.635) levels in RA but not in OA patients. In RA patients, serum IL-34 level did not correlate significantly with variables reflecting inflammation status, joint damage severity, or BMD. However, in RA patients, serum IL-34 level correlated significantly with rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibody titers (r = 0.282 and 0.491, respectively).

Conclusions This study shows for the first time increased IL-34 concentrations in serum and SF in RA patients compared with OA patients and controls. Circulating IL-34 level is significantly associated with RF and anti-CCP antibody titers. These observations suggest a link between IL-34 and RA pathogenesis.


  1. Lin H et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science (New York, NY) 2008; 320:807-811.

  2. Chen Z et al. The critical role of IL-34 in osteoclastogenesis. PloS one 2011; 6: e18689.

Acknowledgements This research was partially supported by grants from Daewoong Pharmaceuticals Corporations.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.